BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 83916)

  • 1. Hemocytometer leukocyte adherence inhibition technique.
    Maluish AE; Halliday WJ
    Cancer Res; 1979 Feb; 39(2 Pt 2):625-6. PubMed ID: 83916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
    Thomson DM
    Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of the microtest version of the leukocyte adherence inhibition assay.
    Goldrosen MH; Howell JH; Holyoke ED
    Cancer Res; 1979 Feb; 39(2 Pt 2):630-2. PubMed ID: 367588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Mr 40,000 polypeptide from colorectal cancer which expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition.
    Artigas C; Thomson DM; Durko M; Sutherland M; Scanzano R; Shenouda G; Dubois AE
    Cancer Res; 1986 Apr; 46(4 Pt 1):1874-81. PubMed ID: 2418955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the hemocytometer and tube modifications of the leukocyte adherence inhibition assay -- II. Application of both modifications for detection of anti-tumor immunity in man.
    Schimke R; Holán V; Sibl O; Hasek M; Ambrosius H
    Neoplasma; 1981; 28(3):257-64. PubMed ID: 7027056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between the macrophage migration inhibition test (MMI) and the leucocyte adherence inhibition test (LAI) in patients with melanoma and carcinoma of the colon.
    Isbister WH
    N Z Med J; 1978 Oct; 88(622):327-30. PubMed ID: 366475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to tumor-associated antigens in vasectomized men.
    Anderson DJ; Alexander NJ; Fulgham DL; Vandenbark AA; Burger DR
    J Natl Cancer Inst; 1982 Sep; 69(3):551-5. PubMed ID: 6180209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of murine tumor-associated antigens by the micro-leukocyte adherence inhibition assay.
    Howell JH; Russo AJ; Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):612-8. PubMed ID: 83914
    [No Abstract]   [Full Text] [Related]  

  • 11. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
    Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
    Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between the leukocyte adherence inhibition microassay and in vivo tests of transplantation resistance.
    Leveson SH; Howell JH; Paolini NS; Tan MH; Holyoke ED; Goldrosen MH
    Cancer Res; 1979 Feb; 39(2 Pt 2):582-6. PubMed ID: 367584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experiences with leukocyte adherence inhibition in human cancer.
    Maluish AE
    Cancer Res; 1979 Feb; 39(2 Pt 2):644-8. PubMed ID: 367590
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of leukocyte adherence by 3-M potassium chloride extracts of human colorectal tumors.
    Ichiki AT; Quirin YP; Collmann IR; Sonoda T; Krauss S
    J Natl Cancer Inst; 1980 Mar; 64(3):419-23. PubMed ID: 6986496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the mechanism of the leukocyte adherence inhibition test.
    Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
    Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
    Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
    Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans.
    Hellström KE; Hellström I
    Cancer Res; 1979 Feb; 39(2 Pt 2):649-50. PubMed ID: 83919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
    Raina S; Russo AJ; Jenkins D; Goldrosen MH
    Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and humoral factors involved in the mechanism of the micro-leukocyte adherence inhibition reaction.
    Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Holyoke ED
    Cancer Res; 1979 Feb; 39(2 Pt 2):587-92. PubMed ID: 367585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of specific immunoreactivity by LAI assay in patients with malignant melanoma of uveal tissue.
    Kalafut F; Cernák A; Pham Manh Hung
    Neoplasma; 1979; 26(3):299-305. PubMed ID: 394010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.